Cargando…
Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance
Drug resistance constitutes a major challenge in designing melanoma therapies. Microenvironment-driven tumor heterogeneity and plasticity play a key role in this phenomenon. Melanoma is highly heterogeneous with diverse genomic alterations and expression of different biological markers. In addition,...
Autores principales: | Ahmed, Farzana, Haass, Nikolas K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976798/ https://www.ncbi.nlm.nih.gov/pubmed/29881716 http://dx.doi.org/10.3389/fonc.2018.00173 |
Ejemplares similares
-
Melanoma Plasticity: Promoter of Metastasis and Resistance to Therapy
por: Huang, Fan, et al.
Publicado: (2021) -
Metabolic Plasticity of Melanoma Cells and Their Crosstalk With Tumor Microenvironment
por: Avagliano, Angelica, et al.
Publicado: (2020) -
Tumor microenvironment in non-melanoma skin cancer resistance to photodynamic therapy
por: Cerro, Paulina A., et al.
Publicado: (2022) -
A Model-System to Address the Impact of Phenotypic Heterogeneity and Plasticity on the Development of Cancer Therapies
por: Jong, Eric D., et al.
Publicado: (2019) -
Reversible Adaptive Plasticity: A Mechanism for Neuroblastoma Cell Heterogeneity and Chemo-Resistance
por: Chakrabarti, Lina, et al.
Publicado: (2012)